Swiss All Share Index

Swiss All Share Index handeln
18.082,88 PKT -81,94 PKT -0,45 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

ISIN CH0009111011


Analysen zu Swiss All Share Index-Werten

Datum Rating Analyst
02.07.12 Schindler kaufen Die Actien-Börse
02.07.12 SGS SA kaufen Die Actien-Börse
29.06.12 Nestlé sector perform RBC Capital Markets
29.06.12 Barry Callebaut sell Société Générale Group S.A. (SG)
28.06.12 Novartis buy Deutsche Bank AG
28.06.12 UBS neutral Sarasin Research
28.06.12 Adecco SA equal-weight Morgan Stanley
28.06.12 Novartis outperform Sanford C. Bernstein and Co., Inc.
27.06.12 Adecco SA outperform Credit Suisse Group
27.06.12 Clariant hold Deutsche Bank AG
27.06.12 Clariant underperform Credit Suisse Group
27.06.12 UBS overweight J.P. Morgan Cazenove
27.06.12 Kühne + Nagel International outperform Credit Suisse Group
27.06.12 Clariant buy Vontobel Research
27.06.12 Galenica hold Vontobel Research
27.06.12 Sika buy Vontobel Research
26.06.12 Swatch (I) buy Goldman Sachs Group Inc.
26.06.12 Swiss Life neutral Goldman Sachs Group Inc.
26.06.12 ABB (Asea Brown Boveri) neutral Exane-BNP Paribas SA
26.06.12 UBS outperform RBC Capital Markets
26.06.12 Kühne + Nagel International buy Nomura
26.06.12 Adecco SA buy Sarasin Research
26.06.12 Adecco SA buy Vontobel Research
25.06.12 UBS buy Banc of America Securities-Merrill Lynch
25.06.12 Holcim neutral J.P. Morgan Cazenove
25.06.12 Zurich Insurance neutral J.P. Morgan Cazenove
25.06.12 Novartis neutral UBS AG
25.06.12 Swiss Re overweight J.P. Morgan Cazenove
25.06.12 UBS neutral Banc of America Securities-Merrill Lynch
25.06.12 Novartis buy UBS AG
25.06.12 UBS kaufen Die Actien-Börse
25.06.12 Clariant underperform Cheuvreux SA
25.06.12 Avolta (ex Dufry) buy Vontobel Research
25.06.12 Clariant buy Vontobel Research
25.06.12 Sonova buy Vontobel Research
25.06.12 UBS hold Vontobel Research
22.06.12 Richemont overweight Barclays Capital
22.06.12 Novartis outperform Credit Suisse Group
22.06.12 Holcim overweight HSBC
22.06.12 Swiss Re overweight J.P. Morgan Cazenove